These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 522916)

  • 1. The passage of lymphatic leukemia L1210 cells injected into glass bead labyrinth: their flow and retention.
    Lewandowska K; Doroszewski J; Szlenk W
    Neoplasma; 1979; 26(4):439-47. PubMed ID: 522916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the flow velocity of cell suspension of the adhesion of lymphocytes and L 1210 cells in a glass surface.
    Jakubas-Przewłocka J
    Bull Acad Pol Sci Biol; 1980; 28(1-2):17-23. PubMed ID: 7272825
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of flow velocity and cell concentration on dynamic adhesion of erythrocytes to glass surface.
    Kowalczynska HM
    J Cell Physiol; 1977 Jun; 91(3):417-28. PubMed ID: 558991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic adhesion of erythrocytes to glass. Comparative study of the influence of serum in low concentrations.
    Kowalczyńska HM
    Arch Immunol Ther Exp (Warsz); 1977; 25(3):397-408. PubMed ID: 889429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
    Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
    Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of hyperthermia on murine bone marrow normal colony-forming units and AKR and L1210 leukemia stem cells.
    Flentje M; Flentje D; Sapareto SA
    Cancer Res; 1984 May; 44(5):1761-6. PubMed ID: 6713379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red blood cells deposit membrane components on contacting surfaces.
    Borenstein N; Brash JL
    J Biomed Mater Res; 1986; 20(6):723-30. PubMed ID: 3722211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactosyltransferase activity and cell growth: uridine diphosphate (UDP)galactose inhibition of murine leukemic L1210 cells.
    Klohs WD; Wilson JR; Weiser MM; Frankfurt O; Bernacki RJ
    J Cell Physiol; 1984 Apr; 119(1):23-8. PubMed ID: 6423650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F; Ueda K; Kawashima K; Jamshedur Rahman SM; Isobe K; Yoshida T; Hasegawa Y; Ando K; Iwamoto T; Nagura E
    J Immunol; 1987 Apr; 138(7):2359-65. PubMed ID: 2951438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.
    Brandsma D; Ulfman L; Reijneveld JC; Bracke M; Taphoorn MJ; Zwaginga JJ; Gebbink MF; de Boer H; Koenderman L; Voest EE
    Neuro Oncol; 2006 Apr; 8(2):127-36. PubMed ID: 16533879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells.
    Guffy MM; North JA; Burns CP
    Cancer Res; 1984 May; 44(5):1863-6. PubMed ID: 6231987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenic enrichment of bone-marrow stromal cells with the use of flow chamber and type I collagen-coated surface.
    Lan CW; Wang FF; Wang YJ
    J Biomed Mater Res A; 2003 Jul; 66(1):38-46. PubMed ID: 12833429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite.
    El-Ghannam A; Ducheyne P; Shapiro IM
    J Orthop Res; 1999 May; 17(3):340-5. PubMed ID: 10376721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of bioadhesion on a flat plate with a yeast/glass model system.
    Mercier-Bonin M; Ouazzani K; Schmitz P; Lorthois S
    J Colloid Interface Sci; 2004 Mar; 271(2):342-50. PubMed ID: 14972611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
    Strzadala L; Opolski A; Radzikowski C; Mihich E
    Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of L1210 cells to sulfonated styrene copolymer surfaces: imaging of F-actin AND alpha-actinin.
    Kowalczyńska HM; Nowak-Wyrzykowska M
    Cell Biol Int; 1999; 23(5):359-72. PubMed ID: 10579902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.